glp-1 weight loss drugs tirzepatide semaglutide Most medications work through a single hormone pathway. works through two. targets GLP-1, a hormone involved in slowing digestion, increasing fullness, and reducing hunger signals. Tirzepatide activates both Lilly orforglipron oral GLP-1 phase

Experts arent entirely sure what causes menopausal heart palpitations, but declining estrogen may play a role, says Nancy Reame, Ph.D., who studies menopause heart palpitations

Gut Health Diagnosis at EverVital Nutrition Are you struggling with side effects of GLP-1 meds like Ozempic face (read about what that is here), diarrhea, constipation, cramping, or bloating

Regular pharmacy- or NHS-initiated monitoring is advisable

Effectiveness Comparison When it comes to semaglutide vs tirzepatide effectiveness, the clinical trial results are staggering: Semaglutide Results Average weight loss: 15-17% of body weight 83% of patients lost at least 5% of their weight 66% lost at least 10% of their weight 48% achieved 15% or greater weight loss Tirzepatide Results Average weight loss: 16-22% of body weight 91% of patients lost at least 5% of their weight 83% lost at least 10% of their weight 57% achieved 20% or greater weight loss To put this in perspective, if you weigh 200 pounds, semaglutide could help you lose 30-34 pounds on average, while tirzepatide could help you lose 32-44 pounds